Dr. John Clarence Lipham, MD

Dr. Lipham practices at Los Angeles - USC Healthcare Center 1 in Los Angeles, California.

Dr. Lipham's NPI, 1639100845, was assigned on July 5, 2006. Dr. Lipham graduated from Medical College Of Wisconsin in 1995. Dr. Lipham holds California license A62161.

Dr. Lipham's primary practice is Los Angeles - USC Healthcare Center 1, at 1510 N San Pablo St, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-9058.

Dr. Lipham's primary practice is Los Angeles - USC Healthcare Center 1 in Los Angeles, California. Dr. Lipham is also affiliated with Keck Hospital of USC. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Lipham to 1 more hospital, 1 group practice or clinic and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lipham practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Lipham's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Lipham is board certified in surgery by the American Board of Surgery. Dr. Lipham is licensed in California.

Dmand AI lists esophagus, stomach, or upper small intestine surgery, gallbladder removal and upper GI endoscopy among the conditions Dr. Lipham treats.

CMS data shows 529 Medicare services from Dr. Lipham across 11 procedure codes in 2024, for 291 Medicare patients. Medicare paid $113,076 for them.

CMS counts 291 Medicare patients who saw Dr. Lipham in 2024. The largest group is 65 to 74, with 149 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lipham's median patient age at 68, with 60% women.

In 2024, Dr. Lipham wrote 12 Medicare Part D claims. 100% of them were for generic drugs. They cover 1 drug, with $7,172 in total drug cost. In 2020, CMS named 41 claims across 3 drugs.

Dr. Lipham accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lipham as offering telehealth. CMS counts 341 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Lipham, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 19 papers to Dr. Lipham, published from 2010 to 2020. 2018 was the busiest year, with 3. Dr. Lipham's most frequent co-authors are Nikolai Alexander Bildzukewicz, MD, Joerg Zehetner, MD and Tom Ryan Demeester, MD.

Dmand AI links Dr. Lipham to 9 clinical trials. 3 are still active or recruiting. Conditions studied include Gastroesophageal Reflux, Esophageal Motility Disorders and Hernia, Hiatal. Torax Medical Incorporated sponsors the most, 3.

CMS Open Payments shows 1,024 general payments to Dr. Lipham from 23 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 87% of the total. Medical Device Business Services, Inc. paid the most, $738,893. It also lists 4 research payments totaling $2,849 from 2017 to 2018.

Dmand AI lists 1 award for Dr. Lipham.

Dr. Lipham graduated from Medical College Of Wisconsin in 1995. Dr. Lipham is a member of ACS.

Dr. Lipham is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.